Ernst Schonbrunn

University of Kansas, Lawrence, KS, United States 
"Ernst Schonbrunn"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Akuffo AA, Alontaga AY, Metcalf R, et al. (2018) Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon. The Journal of Biological Chemistry
Allen BK, Mehta S, Ember SW, et al. (2015) Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4. Scientific Reports. 5: 16924
Chen L, Borcherds W, Wu S, et al. (2015) Autoinhibition of MDMX by intramolecular p53 mimicry. Proceedings of the National Academy of Sciences of the United States of America. 112: 4624-9
Lawrence HR, Luo Y, Gunawan S, et al. (2015) Abstract 3697: Development of a focused non-hydrolyzable phosphopeptide library based on a high affinity SHP2 substrate Cancer Research. 75: 3697-3697
Mishra NK, Urick AK, Ember SW, et al. (2014) Fluorinated aromatic amino acids are sensitive 19F NMR probes for bromodomain-ligand interactions. Acs Chemical Biology. 9: 2755-60
Yang H, Lawrence HR, Kazi A, et al. (2014) Dual aurora a and jak2 kinase blockade effectively suppresses malignant transformation Oncotarget. 5: 2947-2961
Martin MP, Olesen SH, Georg GI, et al. (2013) Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains. Acs Chemical Biology. 8: 2360-5
Schonbrunn E, Betzi S, Alam R, et al. (2013) Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinases. Journal of Medicinal Chemistry. 56: 3768-82
Wu S, Chen L, Becker A, et al. (2012) Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding. Molecular and Cellular Biology. 32: 4821-32
Patel RA, Forinash KD, Pireddu R, et al. (2012) RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. Cancer Research. 72: 5025-34
See more...